Back to MPT Database

Copper Intravaginal Ring (Cu-IVR)

Development of prototypes of long- and short-acting versions of an innovative female-controlled, non-hormonal copper vaginal contraceptive method that may also reduce risk for acquisition of sexually transmitted infections and will be suitable for Phase I human clinical testing.

Development Stage:

Preclinical – Early (Pre1)

Hormonal/Non-Hormonal:

Non-Hormonal

Delivery Route & Method:

Topical - Intravaginal Ring (IVR)

Mechanism of Action:

Inhibits sperm motility; antimicrobial properties against common sexually-transmitted pathogens

Developer:

  • University of California, Davis

Funding:

  • Nat. Institute Child Health & Human Development (NICHD)

Funding Mechanism:

NICHD: R61

Back to MPT Database